BerGenBio
Debra Barker is a seasoned clinical development executive with experience from Novartis, Roche, Smithkline Beecham, and Knoll and served until recently as the Chief Medical and Development Officer at Polyphor Ltd. Dr. Barker has a Diploma in Pharmaceutical Medicine and received an MSc in immunology from the King's College in London and a Medical Degree from the Queens College, Cambridge, UK. She is a UK-Swiss citizen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BerGenBio
BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers